Suppr超能文献

F-FDG-PET/CT 对行根治性膀胱切除术的高危非肌层浸润性膀胱癌患者分期的附加临床价值。

Added Clinical Value of F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.

机构信息

Department of Urology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam, The Netherlands.

Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands; Department of Urology, Leiden UMC, Leiden, The Netherlands.

出版信息

Clin Genitourin Cancer. 2023 Jun;21(3):342-348. doi: 10.1016/j.clgc.2023.02.004. Epub 2023 Feb 22.

Abstract

INTRODUCTION AND OBJECTIVES

18F-fluorodeoxyglucose positron-emission tomography-computed tomography (FDG-PET/CT) is increasingly used in the preoperative staging of patients with muscle-invasive bladder cancer. The clinical added value of FDG-PET/CT in high-risk non-muscle invasive bladder cancer (NMIBC) is unknown. In this study, the value of FDG-PET/CT in addition to contrast enhanced (CE)-CT was evaluated in high-risk NMIBC before radical cystectomy (RC).

MATERIALS AND METHODS

This is a retrospective analysis of consecutive patients with high risk and very-high risk urothelial NMIBC scheduled for RC in a tertiary referral center between 2011 and 2020. Patients underwent staging with CE-CT (chest and abdomen/pelvis) and FDG-PET/CT. We assessed the clinical disease stage before and after FDG-PET/CT and the treatment recommendation based on the stage before and after FDG-PET/CT. The accuracy of CT and FDG-PET/CT for identifying metastatic disease was defined by the receiver-operating curve using a reference-standard including histopathology/cytology (if available), imaging and follow-up.

RESULTS

A total of 92 patients were identified (median age: 71 years). In 14/92 (15%) patients, FDG-PET/CT detected metastasis (12 suspicious lymph nodes and 4 distant metastases). The disease stage changed in 11/92 (12%) patients based on additional FDG-PET/CT findings. FDG-PET/CT led to a different treatment in 9/92 (10%) patients. According to the reference standard, 25/92 (27%) patients had metastases. The sensitivity, specificity and accuracy of FDG-PET/CT was 36%, 93% and 77% respectively, versus 12%, 97% and 74% of CE-CT only. The area under the ROC curve was 0.643 for FDG-PET/CT and 0.545 for CT, P = .036.

CONCLUSION

The addition of FDG-PET/CT to CE-CT imaging changed the treatment in 10% of patients and proved to be a valuable diagnostic tool in a selected subgroup of NMIBC patients scheduled for RC.

摘要

介绍和目的

18F-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(FDG-PET/CT)在肌层浸润性膀胱癌患者的术前分期中越来越多地被使用。FDG-PET/CT 在高危非肌层浸润性膀胱癌(NMIBC)中的临床附加价值尚不清楚。在这项研究中,评估了 FDG-PET/CT 在高危 NMIBC 患者根治性膀胱切除术(RC)前对比增强(CE)-CT 之外的价值。

材料和方法

这是一项连续回顾性分析,纳入了 2011 年至 2020 年期间在三级转诊中心接受 RC 治疗的高危和极高危尿路上皮 NMIBC 患者。患者接受了 CE-CT(胸部和腹部/骨盆)和 FDG-PET/CT 分期。我们评估了 FDG-PET/CT 前后的临床疾病分期,并根据 FDG-PET/CT 前后的分期推荐治疗建议。CT 和 FDG-PET/CT 对识别转移性疾病的准确性通过使用包括组织病理学/细胞学(如有)、影像学和随访的参考标准的受试者工作特征曲线来定义。

结果

共确定了 92 例患者(中位年龄:71 岁)。在 14/92(15%)例患者中,FDG-PET/CT 检测到转移(12 个可疑淋巴结和 4 个远处转移)。根据额外的 FDG-PET/CT 结果,11/92(12%)例患者的疾病分期发生了变化。根据参考标准,25/92(27%)例患者存在转移。FDG-PET/CT 的敏感性、特异性和准确性分别为 36%、93%和 77%,而仅 CE-CT 为 12%、97%和 74%。FDG-PET/CT 的 ROC 曲线下面积为 0.643,CT 为 0.545,P=0.036。

结论

FDG-PET/CT 与 CE-CT 成像联合应用改变了 10%患者的治疗方法,并在接受 RC 治疗的选定高危 NMIBC 患者亚组中证明是一种有价值的诊断工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验